Legal Ally

Hair Relaxer Cancer Lawsuit | September 2023 Update

Our law firms are taking hair relaxer cancer lawsuits in all 50 states of US.  And the may qualification diagnose are:

And the relavant hair relaxer companies are:

  • Dark & Lovely, Ultra Sheet, etc., (L’Oréal, the most prominent defendant, a company worth nearly $225 billion)
  • ORS Olive Oil Hair Relaxer (Namaste, LLC)
  • Just for Me (TCB Naturals/Godrej Consumer Products)
  • Motions (Strength of Nature Global, LLC)
  • Revlon (which is in bankruptcy but appears to have good insurance coverage for chemical hair straightener claims)
Products named in Hair Relaxer Cancer Lawsuit

Most Recent Update On Hair Relaxer Cancer Lawsuit

New evidence shows that exposure to the chemicals in hair relaxers or hair straighteners can cause uterine cancer and other conditions lead to in a hysterectomy treament. Lawsuits are now being filed against cosmetic product companies that manufacture hair relaxers. A class action lawsuit against hair relaxers could be filed as early as this week. Our lawyers are currently looking for cases of hysterectomy cases which caused by hair relaxants.

Our law firm has been and will be the leading source of news, updates, and information about hair relaxer lawsuits in this country. Our attorneys are committed to keeping our clients and other victims informed.  So bookmark this page and come back for the latest information.

September 4, 2023 New Law Firm

One of the lead defendants in the hair relaxer class action lawsuit, Dabur International (parent company of Namaste Laboratories), changed defense counsel this week. Dabur has replaced its defense team from the law firm of Kirkland & Ellis LLC (the lead defense firm in the 3M earplug litigation) with a new team of attorneys from the law firm of Baker & McKenzie LLP. So Dabur is swapping one law firm that has a zillion lawyers for another law firm that has a zillion lawyers.

September 1, 2023 – Status Conference

Last week, there was a status conference before Judge Rowland. First, a deadline of August 30, 2023 was set for a joint written status report on the McBride motions to dismiss. Defendant Dermoviva Skin Essentials Inc. was dismissed from the class action earlier this month (but may still be reinstated).

Second, the parties are discussing disclosure under Federal Rule 26(a)(1) – which relates to experts – and other disclosure issues. There have been discussions about 30(b)(6) depositions and electronic discovery (ESI), particularly with respect to Defendants Beauty Bell, Revlon, and Namaste. A 30(b)(6) deposition, also known as a corporate deposition, is a legal proceeding in which an organization designates one or more of its representatives to testify on its behalf regarding specific topics or areas of inquiry.

Third, the Receiver informed the Court of the status of Revlon’s bankruptcy and subject matter jurisdiction with respect to cases against Revlon. Revlon is rumored to have $1 billion in insurance coverage. So even though the company is bankrupt, it is a major defendant.

Finally, the court informed the parties that frequently asked questions (FAQ) have been posted on the court’s MDL website.

August 26, 2023 – Discovery Battle

A hearing on the status of the investigation is scheduled for October 2, 2023. In mass actions, there are many battles over documents and testimony in these cases and how to proceed. This litigation is no exception.

August 21, 2023 – New Lawsuit

A Brooklyn, Minnesota, woman is one of the latest plaintiffs to join the hair relaxant class action lawsuit yesterday. This new plaintiff filed her hair relaxant lawsuit directly with the MDL using the Short Form Complaint.

According to her complaint, between 1985 and 2011, Hardin used three chemical hair relaxer products: ORS Olive Oil, Just for Me and S&B Botanicals. Strength of Nature, LLC and Namaste Laboratories were the two defendants named in the case. She was diagnosed with endometrial cancer in 2019.

August 18, 2023 – Master Complaint Done

The plaintiffs’ main complaint has been filed. It is an excellent and detailed statement – over 400 pages – of the plaintiffs’ allegations.

August 17, 2023 – MDL Grows to 275 Cases in total

There are now 275 pending cases in the hair relaxant class action lawsuit (MDL). In the last 30 days, another 36 new cases have been added to the MDL. That is some decrease from the previous month, but this is always a very slow time of year for new class actions, and we have seen similar decreases in new filings in all of the other MDLs that we track.

August 14, 2023 – Master Lawsuit Due

Plaintiff’s lead action is due today. In an MDL class action like this one, a master complaint is often filed that combines the common factual and legal claims of all plaintiffs. This does not mean that all of the lawsuits are consolidated into one; they remain individual lawsuits. The master complaint is a complaint that contains all of the allegations that are made in most of the lawsuits against hair shampoos. It serves as a guide for pretrial discovery in the case.

Last week, the court approved a new short form of the complaint. This allows plaintiffs to refer to the new master complaint, making it easier to file a hair relaxant lawsuit.

August 4, 2023 – Short Form Complaint Adopted in MDL

The recent development in the hair relaxer cancer lawsuits is the availability of a direct filing option for new cases in the class action MDL, using the official Short Form Complaint approved by Judge Rowland earlier this week. This option is expected to significantly streamline the process of filing new hair relaxer lawsuits in the MDL and lead to a continued increase in new filings.

L'Oréal, world leader in haircare industry, has now became one of the defendants in this Hair Relaxer Cancer Lawsuit.

July 18, 2023 – MDL Case Filings Reach New Monthly High

As anticipated, the hair relaxer class action litigation is gaining momentum, with 87 new hair relaxer cancer lawsuits added to the MDL last month. This is the highest monthly total of new cases since the inception of the MDL and represents a steady upward trend in new case filings over the past four months. In February, there were only 21 cases pending in the MDL, whereas there are now 236 pending cases.

July 16, 2023 – MDL Court Orders

Following a hearing, the MDL judge has directed defendants to respond to plaintiffs’ interrogatories seeking identification of the products and product IDs by noon central time on Tuesday, July 18, 2023. By July 21, 2023, the interrogatories must be verified and can be supplemented if necessary. The parties are encouraged to discuss and negotiate the remaining interrogatory responses and request deadline extensions if required. Furthermore, the Court has raised the issue of incorporating an additional question on the Short Form Complaint to establish subject matter jurisdiction.

The next status hearing is scheduled for August 23, 2023, at 1:00 pm CST.

July 5, 2023 – Revlon Update

Revlon has presented an update to the MDL judge regarding their ongoing bankruptcy proceedings and a response to the plaintiffs’ status report, which was submitted on June 30, 2023. Despite being in bankruptcy, Revlon is a significant entity due to its large insurance policy covering hair relaxer cancer lawsuits. Revlon is responsible for several hair relaxer brands, including Crème of Nature, African Pride, French Perm, Fabulaxer, Revlon Professional, Revlon Realistic, Herbarich, and All Ways Natural Relaxer.

Revlon asserts that the plaintiffs’ report inaccurately portrays certain aspects of the bankruptcy proceedings and highlights concerns that have already been addressed. The update includes detailed provisions of the bankruptcy proceedings and confirmation order to guide the court regarding the possible implications on the MDL class action lawsuit. Revlon emphasizes that any claims against it must adhere to the bankruptcy court’s order and proof-of-claim procedures. Furthermore, a plaintiff can only assert “Hair Straightening Claims” in these MDL proceedings or in the Southern District of New York after filing a valid proof of claim.

According to the Plan’s articles, potential plaintiffs must file a hair straightening complaint against Revlon by September 14, 2023. Any recovery for these claims, through settlement or judgment, is considered discharged in bankruptcy if not covered by Revlon’s insurance. Revlon recently filed an omnibus objection to various proofs of claim, including those from approximately 3,000 hair straightening claimants, and expects to file more objections.

Revlon’s update to the court is rather preachy and criticizes the plaintiffs’ lawyers’ status report for its inaccurate portrayal of the bankruptcy court’s order. Additionally, Revlon notes that the hair-straightening-claim objections were resolved before the bankruptcy court’s hearing on the objections, which the plaintiffs’ report omitted.

July 1, 2022 – General Causation First

The defendants have submitted a motion for pretrial discovery with a focus on general causation. It is our understanding that the defendants are seeking to fully understand the underlying causes of the issue at hand. While we acknowledge their request, we believe that it is important to move forward with the case in a timely manner. We understand that both parties have a desire to reach a reasonable settlement, and we believe that setting a trial date will help facilitate this process. We respectfully suggest that delaying the progression of the case may not be in the best interest of all parties involved. We trust that the court will carefully consider all aspects of the case before making a decision on the motion.

Do hair perms cause similar risks as hair relaxers, including uterine cancer?

It has been observed that undergoing a hair perm treatment may potentially expose an individual to similar risks as those associated with the use of hair relaxers. This is due to the presence of cancer-causing toxins in hair chemicals that are commonly utilized in hair smoothing procedures at salons. As a result, there may be a possibility of legal action being taken in relation to hair perm treatments.

The Settlement Amounts for Hair Relaxer Uterine Cancer Lawsuits Can Be Huge

At this stage, it would be premature to speculate on the potential value of hair relaxer uterine cancer lawsuits, either in terms of a trial or settlement. The recent case filed by Jenny Mitchell is the first of its kind, and it remains to be seen whether the scientific evidence linking hair relaxer to cancer will hold up in court. However, our legal team has reviewed the available evidence and finds it to be compelling, which is why many lawyers are now advertising their services to potential victims.

While it is still early in the litigation process, we can offer some initial thoughts on the potential settlement amounts for these cases. Assuming that the causation evidence is sufficient, our lawyers believe that a strong uterine cancer case could result in a settlement payout ranging from $300,000 to $1,750,000. Cases involving younger plaintiffs may be worth even more, given the potential for permanent infertility resulting from uterine cancer.

It is worth noting that the settlement payout will depend on the individual circumstances of each case, including the defendants involved. Larger companies like L’Oréal may have the resources to pay fair settlement amounts and jury payouts, while smaller companies may struggle to do so. We will continue to monitor the situation closely and provide updates as appropriate.

Contact Us To File a Hair Relaxer Cancer Lawsuit

Our firm is currently conducting an investigation into product liability cases that pertain to allegations of chemicals in hair perm and hair relaxer products causing uterine cancer. In the event that you have been diagnosed with uterine cancer after years of regularly using a chemical hair straightener, contact our office today for a free consultation at (855) -614-1600 or to receive a free online consultation.

(000) 000-0000

Leave a Reply